RRM2 is also regarded as a vital component in tumor progression, a regulator of some oncogenes, and a promising tumor biomarker for many cancers, such as lung adenocarcinoma (14), oral squamous cell carcinoma (15), glioblastoma (16), and breast cancer (17). Here, RRM2 is linked to neoplasm.